Evidence map›Paper›PMID 34819576›Full record

ArticleScientific reports2021

High prevalence of multiple antibiotic resistance in clinical E. coli isolates from Bangladesh and prediction of molecular resistance determinants using WGS of an XDR isolate.

Preeti Jain, Asim Kumar Bepari, Prosengit Kumer Sen, Tanzir Rafe, Rashed Imtiaz, Maqsud Hossain, Hasan Mahmud Reza

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prevalence and Antimicrobial Susceptibility ofVeterinary medicine international · 2026
    Article
  10. Article
  11. Article
  12. Patterns of multidrug resistance inJournal of advanced veterinary and animal research · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Antibiotic resistance, virulence gene, phylogenetic group and genetic diversity ofFrontiers in cellular and infection microbiology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Preeti JainDepartment of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh.
Asim Kumar BepariDepartment of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh.
Prosengit Kumer SenDepartment of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh.
Tanzir RafeDepartment of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh.
Rashed ImtiazDepartment of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh.
Maqsud HossainNSU Genome Research Institute (NGRI), North South University, Dhaka, Bangladesh.
Hasan Mahmud RezaDepartment of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh. hasan.reza@northsouth.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multi-drug-resistance (MDR) is a severe public health concern worldwide, and its containment is more challenging in developing countries due to poor antimicrobial resistance (AMR) surveillance and irrational use of antibiotics. The current study investigated 100 clinical E. coli isolates and revealed that 98% of them were MDR. PCR analysis using 25 selected isolates showed the predominance of metallo-β-lactamase gene bla

Indexed as

Genome, BacterialWhole Genome SequencingAnti-Bacterial AgentsBacterial ProteinsBangladeshbeta-LactamasesDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsHumansMicrobial Sensitivity TestsMolecular EpidemiologyPrevalenceVirulence FactorsAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesEscherichia coli ProteinsVirulence Factors

Identifiers

PMID34819576
PMCPMC8613203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.